Skip to Main Content

Paper Details

Comparison of agents using higher dose anti-VEGF therapy for treatment-resistant neovascular age-related macular degeneration.
Graefes Arch Clin Exp Ophthalmol
4
2022
Author NameAffiliation
Tiarnan D L KeenanDivision of Epidemiology & Clinical Applications, National Eye Institute, National Institutes of Health
Emily Y ChewDivision of Epidemiology & Clinical Applications, National Eye Institute, National Institutes of Health
Catherine A CukrasDivision of Epidemiology & Clinical Applications, National Eye Institute, National Institutes of Health
  • 1 - 3

Datasets

Release 1.2